BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10407998)

  • 1. Ceftriaxone associated hemolysis.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 1999 May; 111(9):368-70. PubMed ID: 10407998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
    Citak A; Garratty G; Ucsel R; Karabocuoglu M; Uzel N
    J Paediatr Child Health; 2002 Apr; 38(2):209-10. PubMed ID: 12031011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].
    Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ
    Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.
    Eckman MH; Steere AC; Kalish RA; Pauker SG
    N Engl J Med; 1997 Jul; 337(5):357-63. PubMed ID: 9233874
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication.
    Famularo G; Polchi S; De Simone C
    Ann Ital Med Int; 1999; 14(3):202-4. PubMed ID: 10566187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A 58-year-old woman with disorientation, incoherence and seizures].
    Morera J; Díaz-Marín C
    Rev Neurol; 1997 Jan; 25(137):131-5. PubMed ID: 9091197
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningopapillitis disclosing Lyme disease].
    Gérard P; Canaple S; Rosa A
    Rev Neurol (Paris); 1996; 152(6-7):476-8. PubMed ID: 8944247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone.
    Logigian EL; Kaplan RF; Steere AC
    J Infect Dis; 1999 Aug; 180(2):377-83. PubMed ID: 10395852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of an antibiotic combination on the propagation of Borrelia burgdorferi, causative agent of Lyme disease].
    Lakos A; Nagy G
    Orv Hetil; 1999 Jul; 140(27):1529-32. PubMed ID: 10436750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
    Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and fatal cephalosporin-induced autoimmune haemolytic anaemia.
    Boilève A; Gavaud A; Grignano E; Franck N; Carlotti A; Mira JP; Bouscary D; Jozwiak M
    Br J Clin Pharmacol; 2021 Apr; 87(4):2152-2156. PubMed ID: 33075171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Unusual clinical manifestation of Lyme disease--report of 2 cases].
    Ołdak E; Sulik A; Rozkiewicz D; Pogorzelska E; Pogorzelska M
    Przegl Lek; 2007; 64(12):1031-2. PubMed ID: 18595510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.